AU476623B2 - 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof - Google Patents
3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereofInfo
- Publication number
- AU476623B2 AU476623B2 AU48754/72A AU4875472A AU476623B2 AU 476623 B2 AU476623 B2 AU 476623B2 AU 48754/72 A AU48754/72 A AU 48754/72A AU 4875472 A AU4875472 A AU 4875472A AU 476623 B2 AU476623 B2 AU 476623B2
- Authority
- AU
- Australia
- Prior art keywords
- pregnane
- dione
- hydroxy
- pharmaceutical compositions
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5246671A GB1409240A (en) | 1971-11-11 | 1971-11-11 | Anaesthetic steroid of the 5alpha-pregnane series |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4875472A AU4875472A (en) | 1974-05-16 |
| AU476623B2 true AU476623B2 (en) | 1976-09-30 |
Family
ID=10464023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU48754/72A Expired AU476623B2 (en) | 1971-11-11 | 1972-11-10 | 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3822297A (OSRAM) |
| JP (1) | JPS4861465A (OSRAM) |
| AU (1) | AU476623B2 (OSRAM) |
| BE (1) | BE791196A (OSRAM) |
| CA (1) | CA992068A (OSRAM) |
| DE (1) | DE2255153A1 (OSRAM) |
| DK (1) | DK131296B (OSRAM) |
| ES (1) | ES408509A1 (OSRAM) |
| FR (1) | FR2159447B1 (OSRAM) |
| GB (1) | GB1409240A (OSRAM) |
| IE (1) | IE37076B1 (OSRAM) |
| IL (1) | IL40790A (OSRAM) |
| NL (1) | NL7215225A (OSRAM) |
| PH (1) | PH9928A (OSRAM) |
| SE (1) | SE390025B (OSRAM) |
| ZA (1) | ZA727971B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3952031A (en) * | 1970-11-12 | 1976-04-20 | Glaxo Laboratories Limited | Anaesthetic composition containing a steroid of the 5α-pregnane series and method of using same |
| DE2438020A1 (de) * | 1974-08-05 | 1976-02-26 | Schering Ag | 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung |
| US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| AUPN498095A0 (en) * | 1995-08-23 | 1995-09-14 | Goodchild, Colin Stanley | Compounds and compositions |
| US6787530B1 (en) | 1996-08-23 | 2004-09-07 | Monash University | Use of pregnane-diones as analgesic agents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1281205A (fr) * | 1956-12-21 | 1962-01-12 | Organon Nv | Procédé d'obtention de composés de la série du prégnane |
-
0
- BE BE791196D patent/BE791196A/xx unknown
-
1971
- 1971-11-11 GB GB5246671A patent/GB1409240A/en not_active Expired
-
1972
- 1972-11-10 CA CA156,153A patent/CA992068A/en not_active Expired
- 1972-11-10 IE IE1541/72A patent/IE37076B1/xx unknown
- 1972-11-10 NL NL7215225A patent/NL7215225A/xx not_active Application Discontinuation
- 1972-11-10 AU AU48754/72A patent/AU476623B2/en not_active Expired
- 1972-11-10 IL IL40790A patent/IL40790A/xx unknown
- 1972-11-10 DE DE2255153A patent/DE2255153A1/de not_active Ceased
- 1972-11-10 ZA ZA727971A patent/ZA727971B/xx unknown
- 1972-11-10 ES ES408509A patent/ES408509A1/es not_active Expired
- 1972-11-10 DK DK559072AA patent/DK131296B/da unknown
- 1972-11-10 SE SE7214660A patent/SE390025B/xx unknown
- 1972-11-10 JP JP47112189A patent/JPS4861465A/ja active Pending
- 1972-11-10 FR FR7239866A patent/FR2159447B1/fr not_active Expired
- 1972-11-10 US US00305245A patent/US3822297A/en not_active Expired - Lifetime
- 1972-12-10 PH PH14065A patent/PH9928A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA727971B (en) | 1973-09-26 |
| DK131296B (da) | 1975-06-23 |
| CA992068A (en) | 1976-06-29 |
| US3822297A (en) | 1974-07-02 |
| FR2159447A1 (OSRAM) | 1973-06-22 |
| FR2159447B1 (OSRAM) | 1976-08-20 |
| IL40790A0 (en) | 1973-01-30 |
| GB1409240A (en) | 1975-10-08 |
| DK131296C (OSRAM) | 1975-11-17 |
| IL40790A (en) | 1975-05-22 |
| JPS4861465A (OSRAM) | 1973-08-28 |
| DE2255153A1 (de) | 1973-05-24 |
| PH9928A (en) | 1976-06-14 |
| IE37076L (en) | 1973-05-11 |
| NL7215225A (OSRAM) | 1973-05-15 |
| BE791196A (fr) | 1973-05-10 |
| IE37076B1 (en) | 1977-04-27 |
| AU4875472A (en) | 1974-05-16 |
| SE390025B (sv) | 1976-11-29 |
| ES408509A1 (es) | 1976-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU482733B2 (en) | Pharmaceutical compositions | |
| CA974170A (en) | Pharmaceutical compositions | |
| AU476623B2 (en) | 3 7-hydroxy-19-nor-5d-pregnane-11, 20-dione and pharmaceutical compositions thereof | |
| CA944692A (en) | Pharmaceutical composition and process for the preparation thereof | |
| PH11404A (en) | 2(n-substituted-phenylamino)-imidazolines-(2)and pharmaceutical compositions thereof | |
| CA926396A (en) | 2,6-methano-3-benzazocines and preparation thereof | |
| AU461136B2 (en) | Pharmaceutical composition | |
| CA972103A (en) | Concrete-curing and antispalling compositions | |
| CA877310A (en) | 1-aza-(2,3:5,6)-dibenzocycloheptadiene derivatives and compositions thereof | |
| CA866178A (en) | Pharmaceutical compositions and their preparation | |
| CA872267A (en) | Fluorene derivatives and pharmaceutical compositions | |
| AU452240B2 (en) | 21 fluoro-16, 17-dihydroxy pregnane compounds and their derivatives | |
| CA851190A (en) | Sulphonyl-ureas and sulphonyl-semicarbazides, preparation thereof and pharmaceutical compositions | |
| CA962675A (en) | 2,6-methano-3-benzazocines and preparation thereof | |
| CA994764A (en) | 2,6-methano-3-benzazocines and preparation thereof | |
| CA879074A (en) | Pharmaceutical compositions | |
| CA888688A (en) | Pharmaceutical compositions | |
| CA881476A (en) | Pharmaceutical compositions | |
| CA882088A (en) | Pharmaceutical compositions | |
| CA884856A (en) | Pharmaceutical compositions | |
| CA884860A (en) | Pharmaceutical compositions | |
| CA888155A (en) | Pharmaceutical compositions | |
| CA876689A (en) | Pharmaceutical compositions | |
| CA887648A (en) | N-arallyl-n'-aralkyl piperazines and pharmaceutical compositions thereof | |
| CA875539A (en) | N6-aralkyl-adenosine derivatives, preparation and compositions thereof |